Systemic corticosteroid exposure during cutaneous immune related adverse events worsens overall survival

被引：0
|
作者：
Shah, N. [1 ,2 ]
Jacoby, T. V. [1 ,3 ]
Asdourian, M. S. [1 ,4 ]
LeBoeuf, N. [1 ]
Semenov, Y. R. [1 ]
Reynolds, K. [1 ]
Chen, S. [1 ,4 ]
机构：
[1] Mass Gen Brigham Inc, Dermatol, Boston, MA USA
[2] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[3] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB933
引用
收藏
页码：B14 / B14
页数：1
相关论文
共 50 条
  • [31] Immune related adverse events: Timing, identification patterns, and impact on survival
    Deviley, Jake Anthony
    Hayashi-Tanner, Yacki
    Krause, Joshua
    Arenz, Andrea
    Frankki, Susan M.
    Marinier, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
    Yung-Tsu Cho
    Yi-Tsz Lin
    Che-Wen Yang
    Chia-Yu Chu
    Scientific Reports, 12
  • [33] Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
    Cho, Yung-Tsu
    Lin, Yi-Tsz
    Yang, Che-Wen
    Chu, Chia-Yu
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review
    Brown, Alexandria M.
    Masterson, Wylie
    Lo, Jonathan
    Patel, Anisha B.
    DERMATITIS, 2023, 34 (03) : 201 - 208
  • [35] Tissue-specific homing in cutaneous immune-related adverse events
    Leung, B.
    Zhang, S.
    Nguyen, N.
    Wan, G.
    Jairath, R.
    Alexander, N.
    Phillipps, J.
    Zubiri, L.
    Demehri, S.
    Yu, K.
    Gusev, A.
    Kwatra, S. G.
    LeBoeuf, N.
    Reynolds, K.
    Semenov, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S44 - S44
  • [36] Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients
    Momin, Zoha K.
    Gill, Jennifer G.
    Heberton, Meghan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [37] Cutaneous immune-related adverse events are undertreated in advanced cancer patients
    Chang, M.
    Otto, T.
    Jacoby, T.
    Thompson, L.
    Reynolds, K.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (09) : B10 - B10
  • [38] Racial and ethnic differences in cutaneous immune-related adverse events and outcomes
    Pahalyants, V.
    Theodosakis, N.
    Ugwu-Dike, P.
    Murphy, W.
    Klebanov, N.
    Le, T.
    Gusev, A.
    Naranbhai, V.
    Reynolds, K.
    Kwatra, S.
    Semenov, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S99 - S99
  • [39] The Clinical and Histopathological Features of Cutaneous Immune-Related Adverse Events and Their Outcomes
    Hashimoto, Hiroki
    Ito, Takamichi
    Ichiki, Toshio
    Yamada, Yuichi
    Oda, Yoshinao
    Furue, Masutaka
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 13
  • [40] LONG TERM SYSTEMIC CORTICOSTEROID EXPOSURE:ADVERSE EFFECTS
    Stoica, L. E.
    Uculina, M. J.
    Mitroi, M. R.
    Mitroi, G.
    Preda, S. A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S324 - S325
12345